Notice of Results

RNS Number : 6303P

Seraphim Space Investment Trust PLC

13 February 2023

 

SERAPHIM SPACE INVESTMENT TRUST PLC

("Seraphim Space" or "the Company")

Notice of Results

Seraphim Space Investment Trust plc (LSE: SSIT), the world's first   listed S paceTech investment company, will announce its interim results for the period ended 31 December 2022 on Thursday 9 March 2023.

There will be a webinar for equity analysts at 09.30 (UK time) on the day of results. To register for the event, please contact SEC Newgate by email at [e-mail] .

A further presentation for retail investors will be provided at 11.00 (UK time) on the same day. Investors can register for the event by emailing [e-mail] .  

Both presentations will be hosted by the Chair Will Whitehorn and Seraphim Space Manager LLP's CEO Mark Boggett and CIO James Bruegger.

- Ends -

Media Enquiries

Seraphim Space Manager LLP (via SEC Newgate)
Mark Boggett, CEO / James Bruegger, CIO / Rob Desborough  

SEC Newgate (Communications advisers)                                        [e-mail]  
Emma Kane / Clotilde Gros / George Esmond                                                  [phone]
 

Deutsche Bank 
Mark Hankinson / Gavin Deane / Neil Coleman                                        [phone]
 

J.P. Morgan Cazenove
William Simmonds / Jérémie Birnbaum / Rupert Budge  [phone]
 

Ocorian Administration (UK) Limited  [e-mail]  

Lorna Zimny                                                                          [phone]

Notes to Editors:

About Seraphim Space Investment Trust

Seraphim Space Investment Trust plc (the "Company" or "SSIT) is the world's first listed fund focused on SpaceTech. The Company seeks exposure predominantly to early and growth stage private financed SpaceTech businesses that have the potential to dominate globally and that are sector leaders with first mover advantages in areas such as climate, communications, mobility and cyber security.

The Company is listed on the Premium Segment of the London Stock Exchange. Further information is available at:  https://investors.seraphim.vc

 

END

 

 

NORBLGDDSDBDGXG